Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
Genomic rearrangement in anaplastic lymphoma kinase (ALK) gene occurs in 3−7% of patients with non-small-cell lung cancer (NSCLC). The detection of this alteration is crucial as ALK positive NSCLC patients benefit from ALK inhibitors, which improve both the patient's quality of life and overall...
| Prif Awduron: | , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
De Gruyter
2020-03-01
|
| Cyfres: | Advances in Laboratory Medicine |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1515/almed-2019-0019 |